Accepted compounds were subjected to biological screening in a wide array of in vitro biological assays, covering the areas of diabetes/insulin secretion, osteoporosis, Alzheimer's disease, cell division and angiogenesis. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.